We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

505 hedge funds and large institutions have $9.2B invested in Bio-Rad Laboratories Class A in 2023 Q1 according to their latest regulatory filings, with 79 funds opening new positions, 197 increasing their positions, 161 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 39

86% more funds holding in top 10

Funds holding in top 10: 7 → 13 (+6)

22% more repeat investments, than reductions

Existing positions increased: 197 | Existing positions reduced: 161

15% more capital invested

Capital invested by funds: $8.03B → $9.2B (+$1.17B)

7% more funds holding

Funds holding: 471 → 505 (+34)

0.53% more ownership

Funds ownership: 77.8% → 78.33% (+0.53%)

30% less call options, than puts

Call options by funds: $40.2M | Put options by funds: $57.4M

Holders
505
Holders Change
+34
Holders Change %
+7.22%
% of All Funds
8.05%
Holding in Top 10
13
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+85.71%
% of All Funds
0.21%
New
79
Increased
197
Reduced
161
Closed
39
Calls
$40.2M
Puts
$57.4M
Net Calls
-$17.2M
Net Calls Change
+$7.48M

Top Buyers

Rank Fund Capital Flow
1
Los Angeles Capital Management
Los Angeles Capital Management
California
+$86.5M
2
EC
Eminence Capital
New York
+$78.7M
3
Millennium Management
Millennium Management
New York
+$66.6M
4
APM
Avidity Partners Management
Texas
+$60.5M
5
UBS AM
UBS AM
Illinois
+$53.8M

Top Sellers

Rank Fund Capital Flow
1
Amundi
Amundi
France
-$71.5M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$46.1M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$39.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$36.9M
5
A
AustralianSuper
Australia
-$32.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
CTA
501
Colonial Trust Advisors
South Carolina
$479 – – –
NSIM
502
North Star Investment Management
Illinois
$479 – – –
ECM
503
Everence Capital Management
Indiana
$345 – – –
Commonwealth Equity Services
504
Commonwealth Equity Services
Massachusetts
$327 -$25.3K -54 -7%
FGAM
505
Financial Gravity Asset Management
Texas
$266 +$224K +479 New
SFCL
506
Strengthening Families & Communities LLC
Massachusetts
$12 – – –
Balyasny Asset Management
507
Balyasny Asset Management
Illinois
– -$28.2M -67,043 Closed
Voloridge Investment Management
508
Voloridge Investment Management
Florida
– -$24M -57,093 Closed
JF
509
Jump Financial
Illinois
– -$5.22M -12,424 Closed
WMSA
510
Weiss Multi-Strategy Advisers
New York
– -$3.61M -8,585 Closed
Qube Research & Technologies (QRT)
511
Qube Research & Technologies (QRT)
United Kingdom
– -$3.59M -8,532 Closed
MML Investors Services
512
MML Investors Services
Massachusetts
– -$3.57M -8,487 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
513
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$2.95M -7,021 Closed
Walleye Capital
514
Walleye Capital
New York
– -$1.4M -3,330 Closed
PAS
515
Park Avenue Securities
New York
– -$1.29M -3,067 Closed
CCS
516
Concentric Capital Strategies
Connecticut
– -$1.24M -2,960 Closed
CANY
517
Caxton Associates (New York)
New York
– -$1.19M -2,822 Closed
AIM
518
Aigen Investment Management
New York
– -$1.14M -2,719 Closed
Janney Montgomery Scott
519
Janney Montgomery Scott
Pennsylvania
– -$835K -1,985 Closed
Twin Tree Management
520
Twin Tree Management
Texas
– -$726K -1,727 Closed
PTC
521
Petrus Trust Company
Texas
– -$519K -1,235 Closed
OCBCO
522
Oversea-Chinese Banking Corp (OCBC)
Singapore
– -$453K -1,078 Closed
LCS
523
Levin Capital Strategies
New York
– -$356K -847 Closed
SBH
524
Segall Bryant & Hamill
Illinois
– -$200K -477 Closed
PMAM
525
Picton Mahoney Asset Management
Ontario, Canada
– -$149K -354 Closed
18 19 20
21
22

BIO Hedge Fund Activity: Q1 2023 in Review

505 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q1 2023, worth a combined $9.2B — up 15% from $8.03B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new BIO positions and 39 closed out — a net gain of 40 holders — while 197 added to existing stakes and 161 trimmed.

The largest buyer was Los Angeles Capital Management, opening a new position worth an estimated $86.5M. The largest seller was Amundi, cutting an estimated $71.5M.

  • 505 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q1 2023, up from 471 in Q4 2022.
  • Funds reported $9.2B of Bio-Rad Laboratories Class A stock for Q1 2023, up 15% quarter-over-quarter.
  • 79 funds opened new Bio-Rad Laboratories Class A positions in Q1 2023 and 39 closed out, a net change of +40 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q1 2023 was Los Angeles Capital Management, an estimated $86.5M added.
  • The largest Bio-Rad Laboratories Class A seller in Q1 2023 was Amundi, an estimated $71.5M sold.

Based on aggregated 13F filings for Q1 2023.